Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 7/20 | 0.53 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | RXRG | P48443 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.38 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.38 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.38 |
| ▸ | PLAU | P00749 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1648472 | 0.81 | KDM4E (0.45) | FFAR1P4HTMTBXAS1 | |
| SCHEMBL8414096 | 0.79 | P4HTM (0.66) | FFAR1P4HTMKEAP1FFAR4LMNA | |
| SCHEMBL3515895 | 0.78 | FFAR1 (0.55) | FFAR1P4HTMKEAP1NPSR1FFAR4 | |
| SCHEMBL29404687 | 0.78 | FFAR1 (0.55) | FFAR1P4HTMKEAP1RXRARXRB | |
| SCHEMBL25007407 | 0.78 | FFAR1 (0.55) | FFAR1P4HTMKEAP1NPSR1RXRA | |
| SCHEMBL24867307 | 0.78 | FFAR1 (0.55) | FFAR1P4HTMRXRARXRBRXRG | |
| SCHEMBL7996551 | 0.78 | FFAR1 (0.55) | FFAR1P4HTMKEAP1RXRARXRB | |
| SCHEMBL29009736 | 0.78 | FFAR1 (0.55) | FFAR1P4HTMKEAP1RXRARXRB | |
| SCHEMBL2563630 | 0.75 | P4HTM (0.56) | FFAR1P4HTMRXRARXRBRXRG | |
| SCHEMBL24248047 | 0.75 | FFAR1 (0.53) | FFAR1P4HTMKEAP1RXRAFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325486-A1 | AMINOLEVULINIC ACID HYDROCHLORIDE FREEZE-DRIED FORMULATION AND PREPARATION METHOD THEREOF | ZHAOKE PHARMACEUTICAL (HEFEI) CO., LTD (CN) | 2025-10-23 | — | — | US | claimed |
| EP-4516291-A1 | AMINOLEVULINIC ACID HYDROCHLORIDE FREEZE-DRIED FORMULATION AND PREPARATION METHOD THEREFOR | Zhaoke Pharmaceutical (Hefei) Co., Ltd (CN) | 2025-03-05 | — | — | EP | claimed |
| CN-115671059-B | Aminovaleric acid hydrochloride freeze-dried preparation and preparation method thereof | 兆科药业（合肥）有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-115671059-A | Freeze-dried preparation of aminolevulinic acid hydrochloride and preparation method thereof | 兆科药业（合肥）有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-108530243-B | Process for the manufacture of nitriles and their corresponding amines | 中国石化扬子石油化工有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-108546224-B | Process for the manufacture of nitriles and their corresponding amines | 中国石化扬子石油化工有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-108530244-B | Process for the manufacture of nitriles and their corresponding amines | 中国石化扬子石油化工有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-105016941-A | Process for the manufacture of nitriles and their corresponding amines | SINOPEC YANGZI PETROCHEMICAL | 2015-11-04 | — | — | CN | claimed |
| CN-105016945-A | Process for the manufacture of nitriles and their corresponding amines | SINOPEC YANGZI PETROCHEMICAL | 2015-11-04 | — | — | CN | claimed |
| CN-105001033-A | Process for the manufacture of nitriles and their corresponding amines | SINOPEC YANGZI PETROCHEMICAL | 2015-10-28 | — | — | CN | claimed |
| US-20250325486-A1 | AMINOLEVULINIC ACID HYDROCHLORIDE FREEZE-DRIED FORMULATION AND PREPARATION METHOD THEREOF | ZHAOKE PHARMACEUTICAL (HEFEI) CO., LTD (CN) | 2025-10-23 | — | — | US | disclosed |
| EP-4516291-A1 | AMINOLEVULINIC ACID HYDROCHLORIDE FREEZE-DRIED FORMULATION AND PREPARATION METHOD THEREFOR | Zhaoke Pharmaceutical (Hefei) Co., Ltd (CN) | 2025-03-05 | — | — | EP | disclosed |
| CN-118217396-A | Stable aminolevulinic acid hydrochloride granule | 北京普德康利医药科技发展有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-115671059-B | Aminovaleric acid hydrochloride freeze-dried preparation and preparation method thereof | 兆科药业（合肥）有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-117630189-A | Method for detecting hexyl aminolevulinate hydrochloride | 广东精观生物医药科技有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-105016941-A | Process for the manufacture of nitriles and their corresponding amines | SINOPEC YANGZI PETROCHEMICAL | 2015-11-04 | — | — | CN | disclosed |
| CN-105001033-A | Process for the manufacture of nitriles and their corresponding amines | SINOPEC YANGZI PETROCHEMICAL | 2015-10-28 | — | — | CN | disclosed |
| US-8158821-B2 | Crystal of 5-aminolevulinic acid phosphate and process for producing the same | COSMO OIL CO., LTD. (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20100004477-A1 | NOVEL CRYSTAL OF 5-AMINOLEVULINIC ACID PHOSPHATE AND PROCESS FOR PRODUCING THE SAME | COSMO OIL CO., LTD. (JP) | 2010-01-07 | — | — | US | disclosed |
| EP-2053039-A1 | NOVEL CRYSTAL OF 5-AMINOLEVULINIC ACID PHOSPHATE AND PROCESS FOR PRODUCTION THEREOF | Cosmo Oil CO., LTD. (JP) | 2009-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004477-A1 | NOVEL CRYSTAL OF 5-AMINOLEVULINIC ACID PHOSPHATE AND PROCESS FOR PRODUCING THE SAME | ALAD, AASDHPPT, UMPS | FFAR1 2636/4885P4HTM 988/4885KEAP1 4729/4885 |
| US-20250325486-A1 | AMINOLEVULINIC ACID HYDROCHLORIDE FREEZE-DRIED FORMULATION AND PREPARATION METHOD THEREOF | ALAD, AASDHPPT, ABAT | FFAR1 896/4885P4HTM 2864/4885KEAP1 4287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.